The COVID-19 pandemic has devastated the world on a scale not seen in a hundred years. As we enter the final months of 2020, with cases and deaths continuing to rise across the US, researchers are working round the clock to find a vaccine. Here at Fenway Health, we have recently been activated as a trial site for the new CoVPN 3502 COVID-19 antibody study. How can antibodies be used to potentially stop the spread of COVID-19? In the latest episode of Fenway Health’s Pride in Our Health podcast, Dr. Kenneth H. Mayer, Medical Research Director at Fenway Health and Co-Director of The Fenway Institute, provides an in-depth look at this study. The episode explores topics such as:
- How antibodies work
- The difference between an antibody treatment and a vaccine
- A walk-through of clinical research trials
- The safety of antibody studies
- Upcoming COVID-19 vaccine research
- The intersection of HIV and COVID-19 research
- How you can join this COVID-19 antibody trial
Listen to the episode here or subscribe to Pride in Our Health on Apple Podcasts, Google Play, or Spotify.